Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pippa J Tyrrell

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|May 15, 2016
Weekly variation in health-care quality by day and time of admission: a nationwide, registry-based, prospective cohort study of acute stroke careBenjamin D Bray, Geoffrey C Cloud, Martin A James, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2016
The association between delays in screening for and assessing dysphagia after acute stroke, and the risk of stroke-associated pneumoniaBenjamin D Bray, Craig J Smith, Geoffrey C Cloud, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 14, 2014
Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic strokeRobert Hurford, Sean Rezvani, Mohammad Kreimei, et al.
Implementation Science : IS|April 3, 2014
Did a quality improvement collaborative make stroke care better? A cluster randomized trialMaxine Power, Pippa J Tyrrell, Anthony G Rudd, et al.
Journal of Neuroinflammation|January 4, 2014
The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trialNavneet Singh, Stephen J Hopkins, Sharon Hulme, et al.
Implementation Science : IS|June 4, 2016
Explaining outcomes in major system change: a qualitative study of implementing centralised acute stroke services in two large metropolitan regions in EnglandNaomi J Fulop, Angus I G Ramsay, Catherine Perry, et al.
Journal of Neuroinflammation|November 27, 2012
Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infectionStephen J Hopkins, Catherine J McMahon, Navneet Singh, et al.
Stroke|March 24, 2018
SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 TrialCraig J Smith, Sharon Hulme, Andy Vail, et al.
Health Research Policy and Systems|March 16, 2018
The potential role of cost-utility analysis in the decision to implement major system change in acute stroke services in metropolitan areas in EnglandRachael M Hunter, Naomi J Fulop, Ruth J Boaden, et al.
BMJ (Clinical Research Ed.)|September 25, 2014
Authors' reply to Hill and RuddStephen Morris, Rachael M Hunter, Angus I G Ramsay, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|May 15, 2016
Weekly variation in health-care quality by day and time of admission: a nationwide, registry-based, prospective cohort study of acute stroke careBenjamin D Bray, Geoffrey C Cloud, Martin A James, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2016
The association between delays in screening for and assessing dysphagia after acute stroke, and the risk of stroke-associated pneumoniaBenjamin D Bray, Craig J Smith, Geoffrey C Cloud, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 14, 2014
Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic strokeRobert Hurford, Sean Rezvani, Mohammad Kreimei, et al.
Implementation Science : IS|April 3, 2014
Did a quality improvement collaborative make stroke care better? A cluster randomized trialMaxine Power, Pippa J Tyrrell, Anthony G Rudd, et al.
Journal of Neuroinflammation|January 4, 2014
The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trialNavneet Singh, Stephen J Hopkins, Sharon Hulme, et al.
Implementation Science : IS|June 4, 2016
Explaining outcomes in major system change: a qualitative study of implementing centralised acute stroke services in two large metropolitan regions in EnglandNaomi J Fulop, Angus I G Ramsay, Catherine Perry, et al.
Journal of Neuroinflammation|November 27, 2012
Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infectionStephen J Hopkins, Catherine J McMahon, Navneet Singh, et al.
Stroke|March 24, 2018
SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 TrialCraig J Smith, Sharon Hulme, Andy Vail, et al.
Health Research Policy and Systems|March 16, 2018
The potential role of cost-utility analysis in the decision to implement major system change in acute stroke services in metropolitan areas in EnglandRachael M Hunter, Naomi J Fulop, Ruth J Boaden, et al.
BMJ (Clinical Research Ed.)|September 25, 2014
Authors' reply to Hill and RuddStephen Morris, Rachael M Hunter, Angus I G Ramsay, et al.
Pageof 6